Johns Hopkins researchers develop intranasal DNA vaccine targeting drug-resistant tuberculosis
Researchers developed an intranasal DNA fusion vaccine targeting drug-tolerant tuberculosis persisters. In preclinical models, it improved bacterial clearance and reduced lung inflammation.
Read the full articleYou might also wanna read
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers and their colleagues invented a new vaccine that protects mice from respiratory viruses, bacteria and allergen
med.stanford.edu·4mo agoStudy: Three-in-one vaccine shows promise against ‘tripledemic’
University at Buffalo researchers are developing a single shot for flu, COVID-19 and RSV.
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
A Stanford University team have tested their nasal spray vaccine in animals but still need to do human clinical trials.
bbc.com·4mo agoIbuprofen safely dampens inflammatory markers in 28-patient drug-resistant tuberculosis trial
The Experimental Tuberculosis Unit (UTE) at the Germans Trias i Pujol Research Institute (IGTP) has published in Nature Communications the r
República Dominicana suma dos GeneXpert equipo de alta gama para reforzar el diagnóstico de la tuberculosis
El Ministerio de Salud entregó dos equipos al Servicio Nacional de Salud, con una inversión de RD 3,377,100, para acelerar pruebas molecular
Rapid Drug Susceptibility Testing for Tuberculosis Using Raman-Deuterium Isotope Probing
Accurate and timely drug susceptibility testing (DST) is essential for tuberculosis (TB) management, especially given the global rise of mul
go.acs.org·11d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.